TY - JOUR
T1 - Global kidney health 2017 and beyond
T2 - a roadmap for closing gaps in care, research, and policy
AU - Levin, Adeera
AU - Tonelli, Marcello
AU - Bonventre, Joseph
AU - Coresh, Josef
AU - Donner, Jo Ann
AU - Fogo, Agnes B.
AU - Fox, Caroline S.
AU - Gansevoort, Ron T.
AU - Heerspink, Hiddo J.L.
AU - Jardine, Meg
AU - Kasiske, Bertram
AU - Köttgen, Anna
AU - Kretzler, Matthias
AU - Levey, Andrew S.
AU - Luyckx, Valerie A.
AU - Mehta, Ravindra
AU - Moe, Orson
AU - Obrador, Gregorio
AU - Pannu, Neesh
AU - Parikh, Chirag R.
AU - Perkovic, Vlado
AU - Pollock, Carol
AU - Stenvinkel, Peter
AU - Tuttle, Katherine R.
AU - Wheeler, David C.
AU - Eckardt, Kai Uwe
N1 - Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017/10/21
Y1 - 2017/10/21
N2 - The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5–10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury—a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.
AB - The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5–10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury—a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.
UR - http://www.scopus.com/inward/record.url?scp=85018660023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018660023&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(17)30788-2
DO - 10.1016/S0140-6736(17)30788-2
M3 - Review article
AN - SCOPUS:85018660023
SN - 0140-6736
VL - 390
SP - 1888
EP - 1917
JO - The Lancet
JF - The Lancet
IS - 10105
ER -